Advanced Biomedical Technologies Inc. — key financial figures for fiscal year 2020 (in USD), standardized from XBRL/iXBRL filings by Hub-Equity:

Revenue (FY2020)

$123.6K

Net Income/Loss (FY2020)

-$672.0K

Total Assets (FY2020)

$469.2K

Total Equity (FY2020)

-$7.4M

Cash Flows from Operating Activities (FY2020)

$646.7K

Source: Advanced Biomedical Technologies Inc. 10-K filing (FY2020). Full income statement, balance sheet and cash flow, restatement-aware and traceable to the source filing, at Hub-Equity.